Xvivo Perfusion AB Capital Reinvestment Ratio
Xvivo Perfusion AB capital reinvestment ratio. Xvivo Perfusion AB (XVIVO) has a Capital Reinvestment Ratio of 0.22x as of June 2026, meaning it reinvests 0% of its operating cash flow (Skr63.49 Million) in capital expenditures (Skr13.80 Million). Check Xvivo Perfusion AB cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Xvivo Perfusion AB (2011–2025)
Capital reinvestment ratio of Xvivo Perfusion AB from 2011 to 2025. This chart tracks Xvivo Perfusion AB's Capital Reinvestment Ratio across 12 annual periods. Also explore XVIVO net asset momentum to track the company's year-over-year net asset growth rate.
Xvivo Perfusion AB Capital Reinvestment Ratio by Year (2011–2025)
Xvivo Perfusion AB capital reinvestment ratio by year from 2011 to 2025. For the full cash flow conversion analysis, see XVIVO cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.00x | Skr101.07 Million | Skr101.07 Million | ▼ -42.4% |
| 2024 | 1.74x | Skr111.29 Million | Skr193.15 Million | ▲ +86.8% |
| 2023 | 0.93x | Skr46.29 Million | Skr43.02 Million | ▼ -80.2% |
| 2022 | 4.70x | Skr27.86 Million | Skr130.95 Million | ▲ +65.7% |
| 2019 | 2.84x | Skr29.50 Million | Skr83.69 Million | ▲ +22.5% |
| 2018 | 2.32x | Skr23.63 Million | Skr54.71 Million | ▲ +47.1% |
| 2017 | 1.57x | Skr22.19 Million | Skr34.93 Million | ▼ -3.7% |
| 2016 | 1.63x | Skr12.55 Million | Skr20.51 Million | ▲ +6.1% |
| 2015 | 1.54x | Skr8.58 Million | Skr13.21 Million | ▲ +64.7% |
| 2013 | 0.94x | Skr13.46 Million | Skr12.59 Million | ▼ -47.3% |
| 2012 | 1.77x | Skr1.67 Million | Skr2.96 Million | ▲ +96549.9% |
| 2011 | 0.00x | Skr14.17 Million | Skr26.00K | — |